Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 011325
Company: APOTHECON
Company: APOTHECON
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
VESPRIN | TRIFLUPROMAZINE HYDROCHLORIDE | 20MG/ML | INJECTABLE;INJECTION | Discontinued | None | No | No |
VESPRIN | TRIFLUPROMAZINE HYDROCHLORIDE | 10MG/ML | INJECTABLE;INJECTION | Discontinued | None | No | No |
VESPRIN | TRIFLUPROMAZINE HYDROCHLORIDE | 3MG/ML | INJECTABLE;INJECTION | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
01/06/1958 | ORIG-1 | Approval | Type 3 - New Dosage Form | STANDARD |
Label is not available on this site. |